Product Information
LO-ZUMANDIMINE 3 MG-0.02 MG TB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1895 per EA under NDC 59651002988. Its NADAC has been published 366 times since Aug 21, 2019.
FDA first approved this application on Feb 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Aurobindo Pharma LimitedNDC
59651002988
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA209632FDA Approved
2/27/2018
TE Code
AB
On Market Since
2/27/2018
Price Statistics
The NADAC for LO-ZUMANDIMINE 3 MG-0.02 MG TB has been published 366 times since Aug 21, 2019, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $0.4650 (Sep 16, 2020) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1933 |
| 52-week low | $0.1538 |
| Median price | $0.2924 |
| Average price | $0.2885 |
| Largest weekly change | -32.1% (Nov 20, 2024) |
| Weeks tracked | 366 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LO-ZUMANDIMINE 3 MG-0.02 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LO-ZUMANDIMINE 3 MG-0.02 MG TB, manufactured by Aurobindo Pharma Limited, is $0.1895 per EA (NDC 59651002988), effective Aug 19, 2026.
How has the price of LO-ZUMANDIMINE 3 MG-0.02 MG TB changed over time?
Over the history we have for it, the NADAC for LO-ZUMANDIMINE 3 MG-0.02 MG TB has declined 57.4%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for LO-ZUMANDIMINE 3 MG-0.02 MG TB?
Since Aug 21, 2019, the NADAC for LO-ZUMANDIMINE 3 MG-0.02 MG TB has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.4650 (Sep 16, 2020), with a median of $0.2924 per EA.
Are there cheaper alternatives to LO-ZUMANDIMINE 3 MG-0.02 MG TB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZUMANDIMINE 3 MG-0.03 MG TAB, is $0.1492 per EA — about 21% below LO-ZUMANDIMINE 3 MG-0.02 MG TB.
Who manufactures LO-ZUMANDIMINE 3 MG-0.02 MG TB?
LO-ZUMANDIMINE 3 MG-0.02 MG TB (NDC 59651002988) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.